cas 2034526-45-7|| where to buy 2-{1-[4-chloro-3-(trifluoromethyl)benzenesulfonyl]azetidin-3-yl}-1,2,3,4-tetrahydroisoquinoline

Nom du produit:2-{1-[4-chloro-3-(trifluoromethyl)benzenesulfonyl]azetidin-3-yl}-1,2,3,4-tetrahydroisoquinoline

IUPAC Name:2-{1-[4-chloro-3-(trifluoromethyl)benzenesulfonyl]azetidin-3-yl}-1,2,3,4-tetrahydroisoquinoline

: CAS：2034526-45-7; Formule moléculaire：C19H18ClF3N2O2S; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2034526-45-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2034526-45-7; Formule moléculaire:C19H18ClF3N2O2S; Point de fusion:-; Code SMILES:FC(F)(F)C1=C(Cl)C=CC(=C1)S(=O)(=O)N1CC(C1)N1CCC2=C(C1)C=CC=C2; Densité:

: Numéro de catalogue:CM844166; Poids moléculaire:430.87; Point d'ébullition:; N° Mdl:; Stockage:

: Azetidines; Azetidines are an important class of saturated four-membered nitrogen-containing heterocyclic compounds. The research hotspots related to this structure mainly focus on two aspects: one is the research of pharmaceutical chemistry; the other is related to chiral azetidines, using rigid azetidine compounds as chiral ligands for asymmetric catalytic reactions. Many nitrogen-containing heterocycles play important roles in drug structures, and in many cases small structural changes can improve ligand selectivity and pharmacokinetic properties.; Where to buy Azetidines; Where to buy ADC-Cytotoxins? Chemenu Provide Azetidines with high quality and competitive price. Contact us Now.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.